| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |